Related Experiment Video

Updated: May 26, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Oncotype DX test on unequivocally HER2-positive cases: potential for harm

Rohit Bhargava, David J Dabbs

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |January 11, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
    11:34

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

    Published on: December 5, 2017

    Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
    08:28

    Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

    Published on: May 9, 2025

    Related Experiment Videos

    Last Updated: May 26, 2026

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
    11:34

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

    Published on: December 5, 2017

    Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
    08:28

    Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

    Published on: May 9, 2025

    Related Concept Videos

    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

    Articles linked to this work by shared authors, journal, and citation graph.

    Hallucination Detection in Virtually-Stained Histology: A Latent Space Baseline.

    IEEE transactions on medical imaging·2026

    Predicting human mRNA isoform levels from site-specific splicing kinetics in silico.

    bioRxiv : the preprint server for biology·2026

    Label-free multimodal nonlinear microscopy enabled by an optical parametric generator.

    APL photonics·2026

    Survivor Perspectives on Artificial Intelligence Integration in Breast Cancer Treatment: A Qualitative Study of Trust, Equity, and Application.

    European journal of breast health·2026

    Cytologic Detection of Metastatic Immature Teratomas in Two Young Patients With Unique Presentations.

    Diagnostic cytopathology·2026

    Determination of an optimal quality control method for Pap test analysis using digital cytology and artificial intelligence.

    Journal of the American Society of Cytopathology·2026

    COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Contemporary Management of Relapsed or Refractory Chronic Lymphocytic Leukemia.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Systemic Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    GATA1 knockdown enhances CD8+ T cell responses and protects against immune escape in cervical squamous cell carcinoma through FGL1 downregulation.

    Journal of molecular histology·2026

    Tolerability of [161Tb]Tb-SibuDAB in comparison to other PSMA-targeting radioligands in the preclinical setting.

    European journal of nuclear medicine and molecular imaging·2026

    Efficacy and safety of adjuvant CDK4/6 inhibitors in hormone receptor-positive, HER2-negative early breast cancer: Updated evidence from a systematic review and meta-analysis.

    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

    Decision-to-outcome analysis of multidisciplinary tumor board-managed NSCLC patients.

    Turk gogus kalp damar cerrahisi dergisi·2026

    Electronic Structure Engineering at C7 Position of Thieno-Cytosine (thC): Toward Optimal Probe-Adduct Interactions with ABPG in DNA.

    The journal of physical chemistry. B·2026

    How Functional Variants Reconfigure the Rac2 Conformational Landscape.

    The journal of physical chemistry. B·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us